• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2023

    3/9/23 10:00:39 AM ET
    $ABM
    $BIGC
    $BLCO
    $CRGO
    Diversified Commercial Services
    Consumer Discretionary
    Computer Software: Prepackaged Software
    Technology
    Get the next $ABM alert in real time by email

    Upgrades

    For HNI Corp (NYSE:HNI), Sidoti & Co. upgraded the previous rating of Neutral to Buy. For the fourth quarter, HNI had an EPS of $0.63, compared to year-ago quarter EPS of $0.43. At the moment, the stock has a 52-week-high of $39.54 and a 52-week-low of $24.61. HNI closed at $26.82 at the end of the last trading period.

    According to Credit Suisse, the prior rating for Nuvei Corp (NASDAQ:NVEI) was changed from Neutral to Outperform. In the fourth quarter, Nuvei showed an EPS of $0.47, compared to $0.47 from the year-ago quarter. At the moment, the stock has a 52-week-high of $79.13 and a 52-week-low of $23.71. Nuvei closed at $36.41 at the end of the last trading period.

    According to Citigroup, the prior rating for Exact Sciences Corp (NASDAQ:EXAS) was changed from Neutral to Buy. For the fourth quarter, Exact Sciences had an EPS of $0.72, compared to year-ago quarter EPS of $1.28. The current stock performance of Exact Sciences shows a 52-week-high of $76.94 and a 52-week-low of $29.27. Moreover, at the end of the last trading period, the closing price was at $65.00.

    For EnLink Midstream LLC (NYSE:ENLC), Citigroup upgraded the previous rating of Neutral to Buy. For the fourth quarter, EnLink Midstream had an EPS of $0.33, compared to year-ago quarter EPS of $0.11. At the moment, the stock has a 52-week-high of $13.58 and a 52-week-low of $7.77. EnLink Midstream closed at $11.14 at the end of the last trading period.

    According to Barclays, the prior rating for Hilton Worldwide Holdings Inc (NYSE:HLT) was changed from Equal-Weight to Overweight. Hilton Worldwide Holdings earned $1.59 in the fourth quarter, compared to $0.72 in the year-ago quarter. At the moment, the stock has a 52-week-high of $167.99 and a 52-week-low of $108.41. Hilton Worldwide Holdings closed at $147.44 at the end of the last trading period.

    According to B of A Securities, the prior rating for Vertex Inc (NASDAQ:VERX) was changed from Underperform to Neutral. In the fourth quarter, Vertex showed an EPS of $0.08, compared to $0.08 from the year-ago quarter. At the moment, the stock has a 52-week-high of $19.30 and a 52-week-low of $9.44. Vertex closed at $18.57 at the end of the last trading period.

    For VICI Properties Inc (NYSE:VICI), Keybanc upgraded the previous rating of Sector Weight to Overweight. VICI Props earned $0.51 in the fourth quarter, compared to $0.44 in the year-ago quarter. The current stock performance of VICI Props shows a 52-week-high of $35.69 and a 52-week-low of $26.42. Moreover, at the end of the last trading period, the closing price was at $33.76.

    See all analyst ratings upgrades.

    Downgrades

    For loanDepot Inc (NYSE:LDI), B of A Securities downgraded the previous rating of Outperform to Market Perform. In the fourth quarter, loanDepot showed an EPS of $0.35, compared to $0.09 from the year-ago quarter. At the moment, the stock has a 52-week-high of $4.47 and a 52-week-low of $1.25. loanDepot closed at $1.89 at the end of the last trading period.

    CL King downgraded the previous rating for United Natural Foods Inc (NYSE:UNFI) from Buy to Neutral. For the second quarter, United Natural Foods had an EPS of $0.78, compared to year-ago quarter EPS of $1.13. The stock has a 52-week-high of $49.56 and a 52-week-low of $26.60. At the end of the last trading period, United Natural Foods closed at $29.47.

    Benchmark downgraded the previous rating for The Trade Desk Inc (NASDAQ:TTD) from Hold to Sell. Trade Desk earned $0.38 in the fourth quarter, compared to $0.42 in the year-ago quarter. At the moment, the stock has a 52-week-high of $76.75 and a 52-week-low of $39.00. Trade Desk closed at $58.22 at the end of the last trading period.

    According to William Blair, the prior rating for loanDepot Inc (NYSE:LDI) was changed from Outperform to Market Perform. loanDepot earned $0.35 in the fourth quarter, compared to $0.09 in the year-ago quarter. The current stock performance of loanDepot shows a 52-week-high of $4.47 and a 52-week-low of $1.25. Moreover, at the end of the last trading period, the closing price was at $1.89.

    For Ranger Oil Corp (NASDAQ:ROCC), Truist Securities downgraded the previous rating of Buy to Hold. For the fourth quarter, Ranger Oil had an EPS of $4.95, compared to year-ago quarter EPS of $1.73. At the moment, the stock has a 52-week-high of $53.59 and a 52-week-low of $27.26. Ranger Oil closed at $42.03 at the end of the last trading period.

    For Guardant Health Inc (NASDAQ:GH), Citigroup downgraded the previous rating of Buy to Neutral. For the fourth quarter, Guardant Health had an EPS of $1.17, compared to year-ago quarter EPS of $0.69. The stock has a 52-week-high of $77.72 and a 52-week-low of $24.63. At the end of the last trading period, Guardant Health closed at $28.88.

    According to Credit Suisse, the prior rating for Fortune Brands Innovations Inc (NYSE:FBIN) was changed from Neutral to Underperform. In the fourth quarter, Fortune Brands showed an EPS of $1.07, compared to $0.96 from the year-ago quarter. The stock has a 52-week-high of $67.71 and a 52-week-low of $49.51. At the end of the last trading period, Fortune Brands closed at $60.74.

    Baird downgraded the previous rating for ABM Industries Inc (NYSE:ABM) from Outperform to Neutral. ABM Indus earned $0.79 in the first quarter, compared to $0.94 in the year-ago quarter. The current stock performance of ABM Indus shows a 52-week-high of $54.00 and a 52-week-low of $37.68. Moreover, at the end of the last trading period, the closing price was at $47.50.

    For Highwoods Properties Inc (NYSE:HIW), Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. Highwoods Props earned $0.96 in the fourth quarter, compared to $1.06 in the year-ago quarter. At the moment, the stock has a 52-week-high of $47.01 and a 52-week-low of $24.51. Highwoods Props closed at $26.21 at the end of the last trading period.

    For TCR2 Therapeutics Inc (NASDAQ:TCRR), Jefferies downgraded the previous rating of Buy to Underperform. TCR2 Therapeutics earned $0.79 in the third quarter, compared to $0.69 in the year-ago quarter. The current stock performance of TCR2 Therapeutics shows a 52-week-high of $3.88 and a 52-week-low of $0.82. Moreover, at the end of the last trading period, the closing price was at $1.55.

    For Etsy Inc (NASDAQ:ETSY), Jefferies downgraded the previous rating of Buy to Underperform. For the fourth quarter, Etsy had an EPS of $0.77, compared to year-ago quarter EPS of $1.11. The current stock performance of Etsy shows a 52-week-high of $151.50 and a 52-week-low of $67.01. Moreover, at the end of the last trading period, the closing price was at $113.18.

    JP Morgan downgraded the previous rating for Qualtrics International Inc (NASDAQ:XM) from Overweight to Neutral. In the fourth quarter, Qualtrics International showed an EPS of $0.03, compared to $0.07 from the year-ago quarter. The stock has a 52-week-high of $30.95 and a 52-week-low of $9.32. At the end of the last trading period, Qualtrics International closed at $17.24.

    For Diversey Holdings Ltd (NASDAQ:DSEY), Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. In the third quarter, Diversey Hldgs showed an EPS of $0.09, compared to $0.10 from the year-ago quarter. The stock has a 52-week-high of $10.68 and a 52-week-low of $3.95. At the end of the last trading period, Diversey Hldgs closed at $8.18.

    Barclays downgraded the previous rating for Hyatt Hotels Corp (NYSE:H) from Overweight to Equal-Weight. Hyatt Hotels earned $2.55 in the fourth quarter, compared to $2.78 in the year-ago quarter. The current stock performance of Hyatt Hotels shows a 52-week-high of $125.07 and a 52-week-low of $70.12. Moreover, at the end of the last trading period, the closing price was at $119.82.

    According to Itau BBA, the prior rating for Ternium SA (NYSE:TX) was changed from Outperform to Market Perform. For the fourth quarter, Ternium had an EPS of $0.20, compared to year-ago quarter EPS of $5.08. At the moment, the stock has a 52-week-high of $50.36 and a 52-week-low of $26.01. Ternium closed at $45.02 at the end of the last trading period.

    Keybanc downgraded the previous rating for Gaming and Leisure Properties Inc (NASDAQ:GLPI) from Overweight to Sector Weight. For the fourth quarter, Gaming and Leisure Props had an EPS of $0.89, compared to year-ago quarter EPS of $0.85. The current stock performance of Gaming and Leisure Props shows a 52-week-high of $55.13 and a 52-week-low of $41.97. Moreover, at the end of the last trading period, the closing price was at $54.34.

    See all analyst ratings downgrades.

    Initiations

    With a Buy rating, Craig-Hallum initiated coverage on Freightos Ltd (NASDAQ:CRGO). The price target seems to have been set at $10.00 for Freightos. The current stock performance of Freightos shows a 52-week-high of $31.15 and a 52-week-low of $3.95. Moreover, at the end of the last trading period, the closing price was at $4.14.

    Needham initiated coverage on Bausch & Lomb Corp (NYSE:BLCO) with a Hold rating. For the fourth quarter, Bausch & Lomb had an EPS of $0.23, compared to year-ago quarter EPS of $0.35. The stock has a 52-week-high of $20.20 and a 52-week-low of $12.20. At the end of the last trading period, Bausch & Lomb closed at $16.74.

    BTIG initiated coverage on MoonLake Immunotherapeutics (NASDAQ:MLTX) with a Buy rating. The price target for MoonLake is set to $36.00. The stock has a 52-week-high of $25.32 and a 52-week-low of $4.25. At the end of the last trading period, MoonLake closed at $23.70.

    Wells Fargo initiated coverage on Exelixis Inc (NASDAQ:EXEL) with an Overweight rating. The price target for Exelixis is set to $23.00. For the fourth quarter, Exelixis had an EPS of $0.03, compared to year-ago quarter EPS of $0.35. The current stock performance of Exelixis shows a 52-week-high of $23.40 and a 52-week-low of $14.87. Moreover, at the end of the last trading period, the closing price was at $16.36.

    With a Buy rating, EF Hutton initiated coverage on Unicycive Therapeutics Inc (NASDAQ:UNCY). The price target seems to have been set at $5.00 for Unicycive Therapeutics. Unicycive Therapeutics earned $0.37 in the third quarter, compared to $0.37 in the year-ago quarter. At the moment, the stock has a 52-week-high of $2.16 and a 52-week-low of $0.40. Unicycive Therapeutics closed at $1.62 at the end of the last trading period.

    With an Overweight rating, Barclays initiated coverage on Nurix Therapeutics Inc (NASDAQ:NRIX). The price target seems to have been set at $20.00 for Nurix Therapeutics. In the fourth quarter, Nurix Therapeutics showed an EPS of $0.87, compared to $0.85 from the year-ago quarter. The stock has a 52-week-high of $19.91 and a 52-week-low of $7.52. At the end of the last trading period, Nurix Therapeutics closed at $9.05.

    With a Buy rating, DA Davidson initiated coverage on Vtex (NYSE:VTEX). The price target seems to have been set at $5.00 for Vtex. For the fourth quarter, Vtex had an EPS of $0.00, compared to year-ago quarter EPS of $0.06. The current stock performance of Vtex shows a 52-week-high of $7.56 and a 52-week-low of $2.66. Moreover, at the end of the last trading period, the closing price was at $3.78.

    With a Neutral rating, DA Davidson initiated coverage on BigCommerce Holdings Inc (NASDAQ:BIGC). The price target seems to have been set at $11.00 for BigCommerce Holdings. BigCommerce Holdings earned $0.10 in the fourth quarter, compared to $0.17 in the year-ago quarter. At the moment, the stock has a 52-week-high of $24.10 and a 52-week-low of $7.75. BigCommerce Holdings closed at $9.46 at the end of the last trading period.

    UBS initiated coverage on CVR Energy Inc (NYSE:CVI) with a Neutral rating. The price target for CVR Energy is set to $36.00. For the fourth quarter, CVR Energy had an EPS of $1.68, compared to year-ago quarter EPS of $0.20. At the moment, the stock has a 52-week-high of $43.61 and a 52-week-low of $18.48. CVR Energy closed at $32.07 at the end of the last trading period.

    UBS initiated coverage on HF Sinclair Corp (NYSE:DINO) with a Neutral rating. The price target for HF Sinclair is set to $58.00. In the fourth quarter, HF Sinclair showed an EPS of $2.97, compared to $0.11 from the year-ago quarter. At the moment, the stock has a 52-week-high of $66.19 and a 52-week-low of $34.17. HF Sinclair closed at $50.29 at the end of the last trading period.

    With a Neutral rating, UBS initiated coverage on PBF Energy Inc (NYSE:PBF). The price target seems to have been set at $53.00 for PBF Energy. PBF Energy earned $4.41 in the fourth quarter, compared to $1.28 in the year-ago quarter. At the moment, the stock has a 52-week-high of $49.00 and a 52-week-low of $19.23. PBF Energy closed at $45.46 at the end of the last trading period.

    UBS initiated coverage on Delek US Holdings Inc (NYSE:DK) with a Neutral rating. The price target for Delek US Hldgs is set to $29.00. For the fourth quarter, Delek US Hldgs had an EPS of $0.88, compared to year-ago quarter EPS of $0.61. The stock has a 52-week-high of $35.45 and a 52-week-low of $17.70. At the end of the last trading period, Delek US Hldgs closed at $24.54.

    With a Neutral rating, UBS initiated coverage on Par Pacific Holdings Inc (NYSE:PARR). The price target seems to have been set at $34.00 for Par Pacific Hldgs. In the fourth quarter, Par Pacific Hldgs showed an EPS of $2.20, compared to $0.22 from the year-ago quarter. At the moment, the stock has a 52-week-high of $29.89 and a 52-week-low of $11.66. Par Pacific Hldgs closed at $28.57 at the end of the last trading period.

    With a Buy rating, UBS initiated coverage on Marathon Petroleum Corp (NYSE:MPC). The price target seems to have been set at $165.00 for Marathon Petroleum. In the fourth quarter, Marathon Petroleum showed an EPS of $6.65, compared to $1.30 from the year-ago quarter. At the moment, the stock has a 52-week-high of $136.46 and a 52-week-low of $73.17. Marathon Petroleum closed at $127.87 at the end of the last trading period.

    UBS initiated coverage on Valero Energy Corp (NYSE:VLO) with a Buy rating. The price target for Valero Energy is set to $176.00. Valero Energy earned $8.45 in the fourth quarter, compared to $2.47 in the year-ago quarter. The stock has a 52-week-high of $160.16 and a 52-week-low of $83.13. At the end of the last trading period, Valero Energy closed at $132.77.

    Stifel initiated coverage on CSG Systems International Inc (NASDAQ:CSGS) with a Hold rating. The price target for CSG Systems Intl is set to $60.00. For the fourth quarter, CSG Systems Intl had an EPS of $0.84, compared to year-ago quarter EPS of $0.83. The stock has a 52-week-high of $66.58 and a 52-week-low of $52.42. At the end of the last trading period, CSG Systems Intl closed at $55.87.

    See all analyst ratings initiations.

    Get the next $ABM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABM
    $BIGC
    $BLCO
    $CRGO

    CompanyDatePrice TargetRatingAnalyst
    Marathon Petroleum Corporation
    $MPC
    2/4/2026$183.00 → $198.00Buy
    TD Cowen
    Vertex Inc.
    $VERX
    2/3/2026$20.00Overweight → Neutral
    Piper Sandler
    VICI Properties Inc.
    $VICI
    1/30/2026$30.00Sector Outperform → Sector Perform
    Scotiabank
    The Trade Desk Inc.
    $TTD
    1/23/2026Mkt Outperform → Mkt Perform
    Citizens JMP
    Hyatt Hotels Corporation
    $H
    1/22/2026$175.00Outperform → In-line
    Evercore ISI
    ABM Industries Incorporated
    $ABM
    1/21/2026$47.00Buy → Hold
    Truist
    Exact Sciences Corporation
    $EXAS
    1/20/2026$105.00Outperform → Neutral
    Mizuho
    VTEX
    $VTEX
    1/15/2026$4.00Buy → Neutral
    UBS
    More analyst ratings

    $ABM
    $BIGC
    $BLCO
    $CRGO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Pappas James C bought $573,000 worth of shares (17,000 units at $33.71) (SEC Form 4)

    4 - UNITED NATURAL FOODS INC (0001020859) (Issuer)

    1/6/26 8:21:40 AM ET
    $UNFI
    Food Distributors
    Consumer Discretionary

    Director Johnson David Edward bought $1,187,235 worth of shares (27,532 units at $43.12) (SEC Form 4)

    4 - EXELIXIS, INC. (0000939767) (Issuer)

    11/26/25 4:05:28 PM ET
    $EXEL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chief Financial Officer Bodenstedt Matthias bought $98,808 worth of Class A ordinary shares (10,870 units at $9.09), increasing direct ownership by 2% to 627,536 units (SEC Form 4)

    4 - MoonLake Immunotherapeutics (0001821586) (Issuer)

    10/9/25 9:01:51 AM ET
    $MLTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABM
    $BIGC
    $BLCO
    $CRGO
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13D/A filed by PBF Energy Inc.

    SCHEDULE 13D/A - PBF Energy Inc. (0001534504) (Subject)

    2/11/26 8:52:03 PM ET
    $PBF
    Integrated oil Companies
    Energy

    SEC Form 10-K filed by Hilton Worldwide Holdings Inc.

    10-K - Hilton Worldwide Holdings Inc. (0001585689) (Filer)

    2/11/26 10:04:53 AM ET
    $HLT
    Hotels/Resorts
    Consumer Discretionary

    SEC Form 424B5 filed by Highwoods Properties Inc.

    424B5 - HIGHWOODS PROPERTIES, INC. (0000921082) (Filer)

    2/11/26 7:55:10 AM ET
    $HIW
    Real Estate Investment Trusts
    Real Estate

    $ABM
    $BIGC
    $BLCO
    $CRGO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    July 30, 2024 - FDA Roundup: July 30, 2024

    For Immediate Release: July 30, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA is announcing the fiscal year (FY) 2025 user fee rates for importers approved to participate in the Voluntary Qualified Importer Program (VQIP) and accreditation and certification bodies interested in participating in the Accredited Third-Party C

    7/30/24 3:38:18 PM ET
    $GH
    Medical Specialities
    Health Care

    FDA Approval for CABOMETYX issued to EXELIXIS INC

    Submission status for EXELIXIS INC's drug CABOMETYX (SUPPL-16) with active ingredient CABOZANTINIB S-MALATE has changed to 'Approval' on 09/20/2023. Application Category: NDA, Application Number: 208692, Application Classification: Labeling

    9/21/23 4:37:02 AM ET
    $EXEL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for CABOMETYX issued to EXELIXIS INC

    Submission status for EXELIXIS INC's drug CABOMETYX (SUPPL-14) with active ingredient CABOZANTINIB S-MALATE has changed to 'Approval' on 07/14/2022. Application Category: NDA, Application Number: 208692, Application Classification: Efficacy

    7/15/22 4:38:40 AM ET
    $EXEL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ABM
    $BIGC
    $BLCO
    $CRGO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen reiterated coverage on Marathon Petroleum with a new price target

    TD Cowen reiterated coverage of Marathon Petroleum with a rating of Buy and set a new price target of $198.00 from $183.00 previously

    2/4/26 7:58:31 AM ET
    $MPC
    Integrated oil Companies
    Energy

    Vertex downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Vertex from Overweight to Neutral and set a new price target of $20.00

    2/3/26 6:54:33 AM ET
    $VERX
    Computer Software: Prepackaged Software
    Technology

    VICI Properties downgraded by Scotiabank with a new price target

    Scotiabank downgraded VICI Properties from Sector Outperform to Sector Perform and set a new price target of $30.00

    1/30/26 8:41:26 AM ET
    $VICI
    Real Estate Investment Trusts
    Real Estate

    $ABM
    $BIGC
    $BLCO
    $CRGO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Control Empresarial De Capitales S.A. De C.V. sold $8,105,713 worth of Class A Common Shares (229,900 units at $35.26) (SEC Form 4)

    4 - PBF Energy Inc. (0001534504) (Issuer)

    2/11/26 9:06:01 PM ET
    $PBF
    Integrated oil Companies
    Energy

    SEC Form 4 filed by Chief Financial Officer Van Houte Hans

    4 - Nurix Therapeutics, Inc. (0001549595) (Issuer)

    2/10/26 6:09:29 PM ET
    $NRIX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Chief Legal Officer Ring Christine

    4 - Nurix Therapeutics, Inc. (0001549595) (Issuer)

    2/10/26 5:55:00 PM ET
    $NRIX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABM
    $BIGC
    $BLCO
    $CRGO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Bally's Corporation Enters Into Previously Announced Credit Facility and Completes Previously Announced Twin River Lincoln Sale Leaseback

    Bally's Corporation (NYSE:BALY) ("Bally's" or the "Company") announced today that it entered into a new term loan credit facility due 2031, providing it with $1.1 billion of funded term loans (the "Term Loans"). The Term Loans are provided by Ares Management Credit funds, as well as King Street Capital Management and TPG Credit. Separately, the Company completed its previously announced sale and leaseback of the real estate assets of its Twin River Lincoln Casino Resort (the "Lincoln Sale Leaseback"), pursuant to an agreement with GLP Capital, L.P. ("GLP"), a subsidiary of Gaming and Leisure Properties, Inc. (NASDAQ:GLPI). The Lincoln Sale Leaseback provided the Company with total considera

    2/11/26 4:15:00 PM ET
    $BALY
    $GLPI
    Hotels/Resorts
    Consumer Discretionary
    Real Estate Investment Trusts
    Real Estate

    Gaming and Leisure Properties Acquires Real Estate Assets of Bally's Lincoln for $700.0 Million

    WYOMISSING, Pa., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Gaming and Leisure Properties, Inc. (NASDAQ:GLPI) ("GLPI") announced today that it acquired the real estate assets of Bally's Lincoln in Lincoln, Rhode Island, from Bally's Corporation ("Bally's") for $700.0 million. GLPI has posted a presentation, with additional details of the Lincoln property transaction, which can be accessed at www.glpropinc.com. The initial cash rent of $56.0 million represents an 8.0% capitalization rate and equates to a purchase multiple of 12.5x. Bally's Lincoln will be added to the GLPI Bally's Master Lease II agreement, increasing the number of properties to five, and the pro forma rent coverage ratio is expect

    2/11/26 4:15:00 PM ET
    $BALY
    $GLPI
    Hotels/Resorts
    Consumer Discretionary
    Real Estate Investment Trusts
    Real Estate

    VTEX to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on February 26th, 2026

    VTEX (NYSE:VTEX), the backbone for connected commerce, will release the financial results for its fourth fiscal quarter and fiscal year ended December 31st, 2025, via conference call and audio webcast, on February 26th, 2026, at 4:30 pm Eastern Time. The conference call may be accessed by dialing +1-800-715-9871 (Conference ID –3544576–) and requesting inclusion in the call for VTEX. The live conference call can be accessed via audio webcast at the investor relations section of the Company's website at https://www.investors.vtex.com/. An archived webcast replay will be available following the call's conclusion. About VTEX VTEX (NYSE:VTEX) is the commerce suite of choice for bold CIOs

    2/11/26 4:01:00 PM ET
    $VTEX
    Computer Software: Prepackaged Software
    Technology

    $ABM
    $BIGC
    $BLCO
    $CRGO
    Leadership Updates

    Live Leadership Updates

    View All

    ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer

    Brings 20+ years of clinical development experience in autoimmune and inflammatory diseases, including OX40/OX40L program leadership Will build and lead Imagene's clinical organization and drive completion of the Phase 2b ADAPTIVE trial in atopic dermatitis Will expand Phase 2b trial footprint with planned international sites including in the UK and Europe SAN DIEGO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (NASDAQ:IMA, "Imagene, " or the "Company")), today announced the appointment of Dr. Ben Porter-Brown, a seasoned autoimmune and inflammatory drug developer with experience in the OX40 receptor-ligand (OX40-OX40L) inhibition field, as its Chief Medical Officer. He will be fo

    2/10/26 7:00:00 AM ET
    $IMA
    $MLTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Hilton Delivers Strong 6.7% Net Unit Growth in 2025, Closes Year with Record 520,000 Rooms Under Development

    Hilton continues to have more rooms under construction than any other hotel company with approximately one in five rooms under construction globally slated to join the company's portfolio Hilton marked another remarkable year of growth in 2025, adding nearly 800 hotels and 100,000 new rooms to its global portfolio, representing full-year net unit growth of 6.7%. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260126116177/en/ACME Hotel Chicago Outset Collection by Hilton (Photo: Hilton) Owner appetite for Hilton's brands, increased conversion activity and outsized demand for luxury and lifestyle products continued to drive stro

    1/26/26 8:00:00 AM ET
    $HLT
    Hotels/Resorts
    Consumer Discretionary

    Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026

    Planned Leadership Transition Positions Company for Growth Company Expects to Exceed Revenue and Cash Guidance for the Full Year 2025 Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that its Board of Directors (the "Board") has appointed Everett Cunningham as the Company's next President and Chief Executive Officer and a member of the Board, effective January 19, 2026. Mr. Cunningham will succeed Masoud Toloue, who will continue to serve as Chief Executive Officer until Mr. Cunningham assumes the role on January 19, 2026. Following Mr. Cunningham

    1/8/26 4:30:00 PM ET
    $ARVN
    $DGX
    $EXAS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical Specialities
    Biotechnology: Laboratory Analytical Instruments

    $ABM
    $BIGC
    $BLCO
    $CRGO
    Financials

    Live finance-specific insights

    View All

    Gaming and Leisure Properties Acquires Real Estate Assets of Bally's Lincoln for $700.0 Million

    WYOMISSING, Pa., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Gaming and Leisure Properties, Inc. (NASDAQ:GLPI) ("GLPI") announced today that it acquired the real estate assets of Bally's Lincoln in Lincoln, Rhode Island, from Bally's Corporation ("Bally's") for $700.0 million. GLPI has posted a presentation, with additional details of the Lincoln property transaction, which can be accessed at www.glpropinc.com. The initial cash rent of $56.0 million represents an 8.0% capitalization rate and equates to a purchase multiple of 12.5x. Bally's Lincoln will be added to the GLPI Bally's Master Lease II agreement, increasing the number of properties to five, and the pro forma rent coverage ratio is expect

    2/11/26 4:15:00 PM ET
    $BALY
    $GLPI
    Hotels/Resorts
    Consumer Discretionary
    Real Estate Investment Trusts
    Real Estate

    VTEX to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on February 26th, 2026

    VTEX (NYSE:VTEX), the backbone for connected commerce, will release the financial results for its fourth fiscal quarter and fiscal year ended December 31st, 2025, via conference call and audio webcast, on February 26th, 2026, at 4:30 pm Eastern Time. The conference call may be accessed by dialing +1-800-715-9871 (Conference ID –3544576–) and requesting inclusion in the call for VTEX. The live conference call can be accessed via audio webcast at the investor relations section of the Company's website at https://www.investors.vtex.com/. An archived webcast replay will be available following the call's conclusion. About VTEX VTEX (NYSE:VTEX) is the commerce suite of choice for bold CIOs

    2/11/26 4:01:00 PM ET
    $VTEX
    Computer Software: Prepackaged Software
    Technology

    Vertex Announces Fourth Quarter and Full Year 2025 Financial Results

    KING OF PRUSSIA, Pa., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX) ("Vertex" or the "Company"), a leading global provider of indirect tax solutions, today announced financial results for its fourth quarter and full year ended December 31, 2025. "In 2025, Vertex delivered double-digit revenue growth and meaningful profitability improvements while making important investments in the future," said Christopher Young, President and Chief Executive Officer of Vertex. "We sustained our market position as the leading provider of indirect tax solutions to the enterprise and continued to onboard new customers at a healthy pace. In addition, our e-invoicing business enjoyed accelerat

    2/11/26 7:05:00 AM ET
    $VERX
    Computer Software: Prepackaged Software
    Technology

    $ABM
    $BIGC
    $BLCO
    $CRGO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by CVR Energy Inc.

    SC 13D/A - CVR ENERGY INC (0001376139) (Subject)

    1/7/25 6:12:47 AM ET
    $CVI
    Integrated oil Companies
    Energy

    Amendment: SEC Form SC 13D/A filed by loanDepot Inc.

    SC 13D/A - loanDepot, Inc. (0001831631) (Subject)

    12/5/24 7:00:55 PM ET
    $LDI
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13D/A filed by PBF Energy Inc.

    SC 13D/A - PBF Energy Inc. (0001534504) (Subject)

    12/2/24 5:14:26 PM ET
    $PBF
    Integrated oil Companies
    Energy